Compared with adults aged 65 and older, those aged 18 to 64 are more affected by long COVID neurologic symptoms.

“Taken together, these results indicate that, once PNP or NNP patients develop neuro-PASC, whether they contracted SARS-CoV-2 infection prior to, or after SARS-CoV-2 vaccination makes little ...

Ever wake up with that weird metallic taste in your mouth? It's more common than you think, but don't worry, there's a fix!

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced additional follow-up ...

Other adverse reactions (incidence <5%) that occurred more frequently with Rezdiffra compared with placebo were decreased appetite, flatulence, abnormal feces, dysgeusia, vertigo, arrhythmia ...

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients with extra-pancreatic ...

The drug has been in the news recently because of incidents of dysgeusia — a bad ... may see a recurrence of symptoms after a brief recovery. In addition, researchers have found in some cases ...

The researchers observed age-related differences in frequency of neurologic symptoms, including headache, numbness/tingling, dysgeusia, and anosmia, in the NNP group, and blurred vision in the PNP ...

Minor differences in neurologic symptoms were seen between prevaccination ... anosmia (56.6 versus 39.1 percent) and dysgeusia (53.3 versus 37.3 percent) occurred more frequently than for patients ...